相关实验视频
Updated: Sep 14, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
保险覆盖和患者结果:了解食道癌症治疗的变化
Arvind Mukundan1,2, Yaswanth Nagisetti3, Riya Karmakar2
1Department of Chemistry, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, Tamil Nadu, India.
与中国的城乡居民基本医疗保险相比,城市雇员基本医疗保险与更好的食道癌治疗选择和生存率有关. 这会影响患者的治疗结果和死亡风险.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 公共卫生 公共卫生
背景情况:
- 食道癌在中国是一个重大的健康挑战,发病率和死亡率很高.
- 医疗保险类型明显影响患者的财务负担和获得护理的机会.
- 这项研究分析了中国两个主要医疗保险计划对食道癌治疗和生存的影响.
更多相关视频
09:40An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
Published on: April 17, 2020
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
相关概念视频
Cancer Survival Analysis
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...